Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000902664-20-002945
Filing Date
2020-08-10
Accepted
2020-08-10 16:20:39
Documents
2
Period of Report
2020-07-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4662
2 POWER OF ATTORNEY exhibit24_1.htm EX-24.1 6966
  Complete submission text file 0000902664-20-002945.txt   13511
Mailing Address 717 5TH AVENUE 16TH FL. NEW YORK NY 10022
Business Address 717 5TH AVENUE 16TH FL. NEW YORK NY 10022 212-257-4330
Slate Path Capital LP (Reporting) CIK: 0001559706 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38787 | Film No.: 201089646

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Issuer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SLATE PATH CAPITAL LP 717 FIFTH AVENUE, 16TH FLOOR NEW YORK NY 10022
Business Address
Greenspan David Gerald (Reporting) CIK: 0001820641 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38787 | Film No.: 201089647